Moderna Tops BioSpace's Best Places to Work Ranking for Second Consecutive Year

CAMBRIDGE, MA / ACCESSWIRE / November 16, 2022 / Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it was ranked the number one large employer in BioSpace's 2023 Best Places to Work in Biopharma report.

"We are honored to be recognized by BioSpace for the second year in a row as the most desirable large employer in the life sciences industry. To be acknowledged for our innovation and science, as well our commitment to culture, equity, belonging and diversity, is a tribute to our team's dedication as we've grown our global footprint and advanced our pipeline of medicines for patients," said Stéphane Bancel, Chief Executive Officer of Moderna. "We now have more than 3,800 employees globally and continue to grow and invest in our talent, ensuring that the future of Moderna will be even more compelling than the past."

As the Company grows, Moderna is committed to recruiting the best talent from around the world. Moderna reached gender parity as of September 2022 with 50% of its employees' self-identifying as women, including 41% of leaders at the Vice President level or above. Moreover, the Company is committed to identifying and eliminating any pay gaps on the basis of gender and, in connection with its regular reviews, has confirmed pay parity at all levels for all roles globally.

Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it was ranked the number one large employer in BioSpace's 2023 Best Places to Work in Biopharma report .